首页> 外文期刊>European journal of gastroenterology and hepatology >The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome.
【24h】

The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome.

机译:在杜克大学B级结肠直肠癌受试者淋巴结中检测到细胞角蛋白预示结果不佳。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: The objectives of this study were to examine the frequency of lymph node micrometastases detected by keratin immunohistochemistry and their relationship with survival behaviour. METHODS: A total of 133 consecutive patients staged as Duke's B, who had curative resection for colorectal cancer (CRC), comprised the study population. Patients who had died of a non-CRC-related cause or who became lost to follow-up were excluded, resulting in an amended population of 100. Study end-points were defined as disease-free survival of 5 years or CRC-related death. Paraffin-embedded lymph node sections were stained with a commercial cytokeratin antibody using a standard avidin-biotin technique. RESULTS: One quarter of subjects had micrometastases. Fifty-six per cent of subjects with positive lymph nodes had an adverse outcome, compared with 11% of subjects with negative nodes. A highly significant association was found between lymph node cytokeratin expression and mortality in both the univariate (log rank P = 0.0001) and multivariate (Cox proportional hazards P = 0.0123) analysis. CONCLUSIONS: Lymph node micrometastases detected by this inexpensive and simple technique are significantly associated with mortality in Duke's B CRC. This technique may be used to select patients for adjuvant chemotherapy.
机译:目的:本研究的目的是检查通过角蛋白免疫组织化学检测到的淋巴结微转移的频率及其与生存行为的关系。方法:共有133例Duke's B连续患者接受了结直肠癌(CRC)的根治性切除,包括研究人群。因非CRC相关原因死亡或因失访而死亡的患者被排除在外,从而导致100人的修订。研究终点定义为5年无病生存或CRC相关死亡。 。使用标准抗生物素蛋白-生物素技术,用市售细胞角蛋白抗体对石蜡包埋的淋巴结切片进行染色。结果:四分之一的受试者有微转移。淋巴结阳性的受试者中有56%的人有不良结果,而淋巴结阴性的受试者中有11%的人有不良结果。在单变量(对数秩P = 0.0001)和多变量(Cox比例风险P = 0.0123)分析中,淋巴结细胞角蛋白的表达与死亡率之间都存在高度显着的关联。结论:通过这种廉价而简单的技术检测到的淋巴结微转移与Duke's B CRC的死亡率显着相关。该技术可用于选择辅助化疗的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号